SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sean Janzen who wrote (671)2/18/2000 1:59:00 AM
From: Larry G.  Read Replies (2) of 792
 
Again you amaze me with your sleuth abilities.

Presently vancomycin is taken orally where as MBI 853NL is taken topically. You may be right eventually but 853NL is targeting a preventive procedure. This may be a way to get a shoe in the door and later they may expand their targets. Knowing the management at MBI, I tend to think I do not understand what they are doing but the target market is bigger than I think. May be they will get a fast track designation.

I guess the one thing that I appreciate about MBI is that we are investing in a good cause. Some people have asked me to donate money for medical research. I usually reply I already gave my shirt to MBI.

Thanks for the info and have a good day.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News